Nano-X Imaging Shares Are Trading Higher After Nano-X AI Received FDA 510(k) Approval for Its HealthFLD System for Detection of the Early Signs of Fatty Liver Disease
在Nano-X AI的用于检测脂肪肝早期迹象的HealthFLD系统获得美国食品药品管理局510(k)批准后,Nano-X Imaging股价走高
Nano-X Imaging Shares Are Trading Higher After Nano-X AI Received FDA 510(k) Approval for Its HealthFLD System for Detection of the Early Signs of Fatty Liver Disease
在Nano-X AI的用于检测脂肪肝早期迹象的HealthFLD系统获得美国食品药品管理局510(k)批准后,Nano-X Imaging股价走高
使用浏览器的分享功能,分享给你的好友吧